Literature DB >> 19342030

In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.

Dumindra Gurusinghe1, Sharan Gill, Rogelio U Almario, Jennifer Lee, William F Horn, Nancy L Keim, Kyoungmi Kim, Sidika E Karakas.   

Abstract

OBJECTIVE: To investigate adrenal steroid regulation in polycystic ovary syndrome.
DESIGN: Five-hour oral glucose tolerance test (OGTT) and frequently sampled-intravenous gluclose tolerance test.
SETTING: University research center. PATIENT(S): Thirty patients. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Anthropometrics, leptin, cortisol, DHEAS, glucose, insulin. RESULT(S): Morning cortisol correlated with sensitivity index (SI, r = .540), DHEAS correlated inversely with age (r = -.6359), body mass index (BMI, r = -.6199), fat mass (r = -0.630), and leptin (r = -0.5676). Between the second and fourth hour of OGTT, cortisol changes (Delta) exhibited three patterns: I, responders (n = 9, Delta: 10.7 +/- 1.0 microg/dL); II, nonresponders (n = 10, Delta: -3.5 +/- 0.6 microg/dL); III, intermediates (n = 11, Delta: 4.3 +/- 1.0 microg/dL). Compared with nonresponders, responders were more obese (BMI: 37.0 +/- 1.6 vs. 31.7 +/- 1.8 kg/m(2)); had higher leptin (28.9 +/- 1.7 vs. 24.1 +/- 1.1 ng/mL), and lower DHEAS (133 +/- 12 vs. 236 +/- 32 ng/mL), higher glucose at 1 h of OGTT (195 +/- 13 vs. 131 +/- 12 mg/dL), higher area under the curve (AUC)(Glucose) (332 +/- 20 vs. 265 +/- 17 mg/dL), higher AUC(Insulin) (244 +/- 50 vs. 125 +/- 30 muU/mL), and lower nadir glucose (61 +/- 2 vs. 70 +/- 2 mg/dL). CONCLUSION(S): Obesity and insulin resistance are associated with lower morning cortisol and DHEAS but increased cortisol and DHEA responses after glucose ingestion. Morning steroid levels may not reflect the day-long exposure. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342030      PMCID: PMC2856447          DOI: 10.1016/j.fertnstert.2009.03.017

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  43 in total

Review 1.  Measurement of body composition: applications in hormone research.

Authors:  R N Pierson; J Wang; J C Thornton
Journal:  Horm Res       Date:  1997

2.  Leptin interferes with adrenocorticotropin/3',5'-cyclic adenosine monophosphate (cAMP) signaling, possibly through a Janus kinase 2-phosphatidylinositol 3-kinase/Akt-phosphodiesterase 3-cAMP pathway, to down-regulate cholesterol side-chain cleavage cytochrome P450 enzyme in human adrenocortical NCI-H295 cell line.

Authors:  Hao-Ting Hsu; Yuan-Ching Chang; Yi-Ning Chiu; Chien-Liang Liu; King-Jen Chang; Ing-Cherng Guo
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

3.  Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution.

Authors:  V Vicennati; F Calzoni; A Gambineri; L Gagliardi; A M Morselli Labate; F Casimirri; R Pasquali
Journal:  Horm Metab Res       Date:  1998-03       Impact factor: 2.936

4.  Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.

Authors:  Charles J Glueck; Dawit Aregawi; Mahlia Agloria; Magdalena Winiarska; Luann Sieve; Ping Wang
Journal:  Metabolism       Date:  2006-12       Impact factor: 8.694

5.  Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.

Authors:  Wendy Y Chang; Eric S Knochenhauer; Alfred A Bartolucci; Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

6.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

7.  Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

Authors:  Ashim Kumar; Keslie S Woods; Alfred A Bartolucci; Ricardo Azziz
Journal:  Clin Endocrinol (Oxf)       Date:  2005-06       Impact factor: 3.478

8.  Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss.

Authors:  P J Havel; S Kasim-Karakas; W Mueller; P R Johnson; R L Gingerich; J S Stern
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

9.  Adrenal androgen excess in hyperandrogenism: relation to age and body mass.

Authors:  C Morán; E Knochenhauer; L R Boots; R Azziz
Journal:  Fertil Steril       Date:  1999-04       Impact factor: 7.329

10.  The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

Authors:  M Yilmaz; A Biri; A Karakoç; F Törüner; B Bingöl; N Cakir; B Tiras; G Ayvaz; M Arslan
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

View more
  3 in total

Review 1.  Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment.

Authors:  Jim Parker; Claire O'Brien; Jason Hawrelak; Felice L Gersh
Journal:  Int J Environ Res Public Health       Date:  2022-01-25       Impact factor: 3.390

2.  Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.

Authors:  Luciana Tock; Gláucia Carneiro; Andrea Z Pereira; Sérgio Tufik; Maria Teresa Zanella
Journal:  Int J Endocrinol       Date:  2014-05-07       Impact factor: 3.257

3.  Changes in plasma metabolites and glucose homeostasis during omega-3 polyunsaturated fatty acid supplementation in women with polycystic ovary syndrome.

Authors:  Sidika E Karakas; Bertrand Perroud; Tobias Kind; Mine Palazoglu; Oliver Fiehn
Journal:  BBA Clin       Date:  2016-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.